Non-immunogenic
Biomimetic synthesis with minimal xenogeneic antigen risk, reducing rejection and allergic response.
Explore
With regenerative biotech, we safeguard human health and beauty—and realize the regenerative beauty of life.
Grounded in original biomimetic ECM materials, we break past traditional collagen limits to develop safe, high-performance regenerative biomaterials. We empower tissue repair and skin rejuvenation with science—protecting health and beauty so life may renew like the phoenix.
Learn More
Help you lead in your field
We can customize development to meet your needs as closely as possible. Our third-generation biomimetic collagen can advance your industry standing and help you capture the premium market first.
Explore Biomimetic Collagen
Our Technology
Brand new technology-POGMENT® triple-helix biomimetic ECM collagen
LivingPHOENIX's patented biomimetic ECM collagen enables scalable manufacturing, high bioactivity, and batch-to-batch uniformity—moving beyond the limits of animal-derived and microbial recombinant collagen. Synthesized from amino-acid building blocks, it carries no animal-virus or xenogeneic-protein risk; a stable triple helix supports terminal sterilization, with precise sequence control and excellent fiber self-assembly. Ready for cosmetics, aesthetic medicine, and implantable regenerative use—helping you build next-generation skincare, soft-tissue repair, and tissue-engineering scaffolds.
Explore Our TechnologyWe have advanced equipment and safe laboratory facilities
LivingPHOENIX - Laboratory
Deep R&D in collagen ECM materials, with bioactive testing and validation
LivingPHOENIX - Laboratory
Iterate skincare formulations and complete multi-dimensional efficacy studies
LivingPHOENIX - Laboratory
Uphold testing standards and control raw-material and finished-product safety end to end
LivingPHOENIX - Cleanroom
Compliant cleanroom manufacturing that stably brings research into production
Partnership
BD Technology Partnership (for med-device & listed companies)
Raw-material supply, technology licensing, and co-development of Class III implantable devices; equity fees plus guaranteed orders, fee rebate on milestones, and shared long-term product sales.
Contact Us